SIESTA (Sleep of Inpatients: Empower Staff to Act) for Acute Stroke Rehabilitation
1 other identifier
interventional
400
1 country
1
Brief Summary
Given the critical role of sleep in enhancing neural recovery, motor learning, neuroprotection, and neuroplasticity, interventions to enhance sleep that target sleep could improve recovery and rehabilitation outcomes for stroke patients. In this proposal, a multidisciplinary group of researchers with expertise in rehabilitation medicine, sleep medicine, nursing, physical therapy, wearable technologies, and implementation science will adapt, implement and evaluate a state-of-the-art intervention to promote sleep for stroke patients undergoing acute rehabilitation. SIESTA-Rehab, adapted from a previous unit-based intervention, bundles two sleep-promoting interventions to address the unique sleep challenges stroke patients face during acute rehabilitation: (1) nursing education and empowerment to reduce unnecessary disruptions; (2) a systematic protocol to screen, diagnose, and treat sleep-disordered breathing if present during acute stroke rehabilitation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 27, 2018
CompletedFirst Posted
Study publicly available on registry
February 5, 2020
CompletedStudy Start
First participant enrolled
July 21, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 14, 2025
CompletedApril 15, 2026
April 1, 2026
4.8 years
March 27, 2018
April 14, 2026
Conditions
Outcome Measures
Primary Outcomes (4)
Quality Indicator (QI) Score
The QI score is a measure used in the inpatient setting at the Shirley Ryan AbilityLab that has replaced the Functional Independence Measure (FIM). The score can be obtained in all patients, regardless of stroke type or deficit. The QI evaluates level of disability, and how much assistance is needed for a subject to perform activities of daily living. Each item is scored ranging from total assistance to total independence. Items include eating, grooming, bathing, dressing, toiling, bladder/bowel management, transfers, locomotion, stairs, comprehension, etc.
Up to 3 months
Karolinska Sleep Diary
This questionnaire calculates the sleep quality index (SQI) using four items: slept throughout, sleep restless, ease falling asleep, and premature awakenings. A higher SQI indicates better sleep quality. Additionally, three items (ease awakening, refreshed, sufficient sleep) yield an awake score with lower scores indicating better sleep. Items have 5-point verbal anchors, and response alternatives vary with each question. It has been correlated with measures from polysomnography to measure sleep quality the night prior to administration.
Daily during inpatient stay starting with study admission. Average length of stay is 17 days.
Modified Potential Disruptions of Hospital Sleep Questionnaire (PDHSQ)
This subjective questionnaire asks inpatients how specific items disrupted their sleep the prior night from 1 (not disruptive) to 5 (extremely disruptive). Select items correlate with in-hospital actigraphy, and specific items address rehabilitation.
Daily during inpatient stay starting with study admission. Average length of stay is 17 days.
Change in total sleep time as measured by Actigraphy
Small multi-modality research-grade, wireless, and wearable sensors (Philips Actiwatch and Actigraph wGT3X-BT) are used to calculate total sleep time.
Overnight for first and last three nights of their stay. Average length of stay is 17 days.
Secondary Outcomes (16)
Apnea Hypopnea Index (AHI)
One night around admission to the study.
Electronic Chart Audit
Continuously during inpatient stay starting with study admission. Average length of stay is 17 days.
Insomnia Severity Index
baseline upon study admission
Stroke characteristics
baseline upon study admission
Pharmacologic sleep aids
baseline upon study admission
- +11 more secondary outcomes
Study Arms (2)
SIESTA Rehab
EXPERIMENTALStroke floor on which nurses will be receiving training (SIESTA Rehab Education) on how to minimize nighttime disruptions and batching overnight tasks to preserve sleep for patients hospitalized on that floor. Stroke patients admitted to the SIESTA Rehab Unit will be screening for sleep disordered breathing using ApneaLink. Patients hospitalized on this unit will be approached for consent to wear sensors and actigraphy watches during the hospital stay and after discharge.
Control Unit
NO INTERVENTIONPatients on this unit will receive usual care for stroke patients as outlined by SRALab. including routine nursing care without any intervention to promote sleep like SIESTA and routing sleep disorders screenings based on clinician judgement. Patients hospitalized on this unit will also be approached for consent to wear sensors and actigraphy watches during the hospital stay and after discharge.
Interventions
Stroke patients on the SIESTA Rehab unit will be screened for sleep disordered breathing using ApneaLink monitors. Results will be interpreted by a sleep specialist who will then advise the clinical team at SRALab.
Staff nurses will be trained on how to improve sleep in stroke patients in the acute rehabilitation setting.
Eligibility Criteria
You may qualify if:
- Individuals diagnosed with stroke admitted to the Shirley Ryan AbilityLab (inpatient)
- Age 18 or older
- Able and willing to give written consent and comply with study procedures . Medical clearance from physician
You may not qualify if:
- Serious cardiac conditions or neurological degenerative pathologies as co-morbidities (such as multiple sclerosis, Alzheimer's disease, Parkinson's disease, etc.)
- Pregnant or nursing
- Skin allergies or irritation; open wounds
- Utilizing a powered, implanted cardiac device for monitoring or supporting heart function (i.e. pacemaker, defibrillator, or LVAD)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shirley Ryan AbilityLabcollaborator
- Northwestern Universitycollaborator
- University of Chicagolead
Study Sites (1)
Shirley Ryan AbilityLab
Chicago, Illinois, 60611, United States
Related Publications (2)
Sindorf J, Campagnini S, O'Brien MK, Sunderrajan A, Knutson KL, Zee PC, Wolfe L, Arora VM, Jayaraman A. Sleep Following a Stroke: Multimodal Evaluation of Sleep Health and Disruptions and Impact on Recovery During Acute Inpatient Rehabilitation. Neurorehabil Neural Repair. 2025 Jul;39(7):529-541. doi: 10.1177/15459683251335332. Epub 2025 May 6.
PMID: 40326398DERIVEDSindorf J, Szabo AL, O'Brien MK, Sunderrajan A, Knutson KL, Zee PC, Wolfe L, Arora VM, Jayaraman A. Wireless wearable sensors can facilitate rapid detection of sleep apnea in hospitalized stroke patients. Sleep. 2024 Nov 8;47(11):zsae123. doi: 10.1093/sleep/zsae123.
PMID: 38814827DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 27, 2018
First Posted
February 5, 2020
Study Start
July 21, 2020
Primary Completion
May 15, 2025
Study Completion
July 14, 2025
Last Updated
April 15, 2026
Record last verified: 2026-04